There are two types of buyouts (and probably more) that I could see happening at this point. The pharmaceutical company either wants the specific cancer treatment or they want the encapsulation technology for whatever PharmaCyte has the rights to.
My guess, and it’s just a guess, is the specific treatment could get us $2 to 4$, and we hold on to the rest. I have heard $3 to $5 before the last conference call, and before only developing the master cell bank. So I’m going a little lower now.
If it is for the technology... before proven, $5 to $10? (Hope) But why would they sell early after working with this so long?... After it has been proven... Maybe a bidding war? $10 to $40+++?(What I would really like to see) Pure speculation. Nice to dream.
News 
Market Data 
Discover 
AI
